DALLAH HEALTHCARE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.4 SAR | -0.36% |
|
+0.24% | -3.14% |
| May. 13 | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
| Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 3.24B 865M | Sales 2025 * | 3.55B 947M | Capitalization | 16.25B 4.34B |
|---|---|---|---|---|---|
| Net income 2024 * | 445M 119M | Net income 2025 * | 505M 135M | EV / Sales 2024 * | 5.57 x |
| Net Debt 2024 * | 1.81B 482M | Net Debt 2025 * | 1.71B 455M | EV / Sales 2025 * | 5.06 x |
| P/E ratio 2024 * |
36.5
x | P/E ratio 2025 * |
31.4
x | Employees | - |
| Yield 2024 * |
1.5% | Yield 2025 * |
1.81% | Free-Float | 41.94% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.36% | ||
| 1 week | +0.24% | ||
| Current month | +2.09% | ||
| 1 month | +0.60% | ||
| 3 months | -10.05% | ||
| 6 months | +3.61% | ||
| Current year | -3.14% |
1 week
162.60
170.00
1 month
158.20170.00
Current year
158.20194.00
1 year
131.40194.00
3 years
64.40194.00
5 years
34.75194.00
10 years
32.45194.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
| Chairman | 67 | 93-12-31 | |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 0 M€ | 0.00% | - | |
| 0.02% | 112 M€ | +4.59% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 166.4 | -0.36% | 74,478 |
| 24-05-22 | 167 | +0.72% | 47,180 |
| 24-05-21 | 165.8 | -1.54% | 85,450 |
| 24-05-20 | 168.4 | +1.32% | 61,258 |
| 24-05-19 | 166.2 | +0.12% | 22,445 |
Delayed Quote Saudi Arabian S.E., May 23, 2024 at 08:20 am EDT
More quotes
Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitalsâ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicinesâ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Officeâs segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
Calendar
2024-08-05
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
166.4
SAR
Average target price
155.2
SAR
Spread / Average Target
-6.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.14% | 4.33B | |
| -22.44% | 15.75B | |
| +3.60% | 12.47B | |
| +3.98% | 11.73B | |
| +3.69% | 10.24B | |
| +26.63% | 8.51B | |
| -7.49% | 7.38B | |
| +7.08% | 6.78B | |
| +4.83% | 6.25B | |
| +10.21% | 4.2B |
- Stock Market
- Equities
- 4004 Stock
